TidalSense
Gabriel Lambert is an experienced professional in clinical and commercial development, currently serving as the Director of Clinical and Commercial Development and Head of Clinical Operations at TidalSense since August 2022. Previously, Gabriel has held significant roles, including Chair of the Non-Executive Board and Founder and Director at Polygeia, as well as Internal Medical Training at St George's University Hospitals NHS Foundation Trust. Additionally, experience includes positions as an Honorary Clinical Research Fellow at Imperial College London and various medical roles within the NHS. Educational qualifications comprise a Graduate Medicine degree from the University of Cambridge, a Certificate in Learning and Teaching from Queen Mary University of London, and a Diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine. Gabriel has also demonstrated leadership and project management skills through prior work with Education Partnerships Africa and other organizations.
This person is not in any teams
This person is not in any offices
TidalSense
TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company headquartered in Cambridge UK. TidalSense builds AI-driven diagnostic and monitoring solutions for respiratory medicine built on the foundation of the company's novel patented sensor technology, N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, rapid sampled CO2, unlike anything seen before in clinical medicine.